FIELD: medicine.
SUBSTANCE: present invention relates to the field of medicine, namely to a suspension for the administration of fulvestrant to a patient who needs it, containing fulvestrant particles and a carrier. In this case, fulvestrant particles have LD Dv(10) from 1 micron to 3 microns; LD Dv(50) from 2 microns to 35 microns, and LD Dv(90) from 4 microns to 120 microns, and the carrier is a non-oil carrier.
EFFECT: present invention provides for obtaining a fulvestrant composition with improved dosing properties.
20 cl, 15 dwg, 50 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FULVESTRANT COMPOSITIONS AND METHODS OF THEIR USE | 2018 |
|
RU2800869C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
| GUANFACINE-BASED PHARMACEUTICAL COMPOSITIONS, SUITABLE FOR DAILY INTRODUCTION IN FORM OF SINGLE DOSED FORM | 2006 |
|
RU2435573C2 |
| INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE | 2018 |
|
RU2799591C2 |
| LIQUID INHALATION COMPOSITION CONTAINING RPL554 | 2015 |
|
RU2699995C2 |
| DRUG COMBINATIONS | 2014 |
|
RU2708246C2 |
| APPLICATION OF MODAPHINYL AND METHOD FOR OBTAINING A PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2287987C2 |
| DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING | 2014 |
|
RU2698331C2 |
| RAPAMYCIN-CONTAINING COMPOSITION ADMINISTERED BY INHALATION FOR TREATING AGE-RELATED DISEASES | 2015 |
|
RU2718583C2 |
| INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
